The Expanding MASH Market: How Rezdiffra, Wegovy Might Coexist

 
• By Joseph Haas
  
Fatty liver disease
The MASH market will take a turn in the US with a second FDA-approved drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business